logo-loader
Energy
Iofina PLC

Iofina to move into production of CBD oil after Kentucky approves hemp licence

"The directors are determined to explore the isolation of CBD oil and other valuable products from hemp, a market which is currently underdeveloped but rapidly growing,” said chief executive and president, Tom Becker.

cannabis
Iofina expects to make a start on its new business venture in mid-July

Iodine producer Iofina PLC (LON:IOF) shares jumped on Thursday after the firm revealed plans to move into the production of cannabidiol (CBD) oils after receiving conditional approval for a licence to process hemp in Kentucky, US.

The company expects to complete the payment of fees and scheduled orientation in mid-July, allowing it to begin processing hemp.

READ: Iofina to raise up to £7.5mln to pay off debt and expedite construction of new production facility

The group has created a new subsidiary called IofinaEX that will produce CBD oils.

Iofina said it would use its speciality chemical knowledge and apply it to the extraction and isolation of purified CBD products.

The firm said the 2018 Agriculture Improvement Act, which made the cultivation of hemp legal at a federal level, has opened up new opportunities for the CBD market in the US.

“The directors are determined to explore the isolation of CBD oil and other valuable products from hemp, a market which is currently underdeveloped but rapidly growing,” said chief executive and president, Tom Becker.

He added: "The conditional approval for our handler/processor License in Kentucky is an important step forward as we plan to execute the project at IofinaEX, and we look forward to updating the market as we develop this subsidiary further."

In Kentucky, CBD – the non-psychoactive compound of a cannabis plant – is legal. However, tetrahydrocannabinol, or THC, which is the psychoactive compound that gets a user high is not.

Natural for Iofina

FinnCap said the new CBD business, IofinaEx, is seen as a "natural fit for Iofina" both operationally and geographically, with many of the same process required in cannabinoid production as in its iodine extraction and specialty chemicals businesses.

"It’s very early days, but this is a rapidly growing market with high levels of investor interest; no bad thing," the broker said.

The broker repeated a 27p price target on Iofina shares which in afternoon trading were 10.5% higher at 17.65p.

In a separate announcement published later, Iofina said that at its annual general meeting held today, all resolutions put to shareholders were duly passed.

In addition, it revealed the result of its open offer to raise up to £2.04mln, which was announced on 20 May.

The company said it received valid acceptances from qualifying shareholders in respect of 9,464,655 open offer shares, representing 74.19% of the total number of shares available, resulting in gross proceeds of approximately £1.5mln for the firm.

 -- Adds AGM, open offer results; updates share price --.

Quick facts: Iofina PLC

Price: £0.29

Market: LSE
Market Cap: £55.64 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Iofina PLC named herein, including the promotion by the Company of Iofina PLC in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Iofina chief looking at “prudent expansion” in 2016

Iofina plc (LON:IOF) confirmed it remained on track to produce 250-270 metric tonnes of crystalline iodine in the first half of 2016 as it unveiled results for the last financial year. Tom Becker, chief executive, tells Proactive Investors that the 2015 figures were slightly better...

on 05/09/2016

3 min read